U.S. Telehealth Companies Ranked by Market Share (2024)
The U.S. telehealth market in 2024 is valued at approximately $35–45 billion in direct telemedicine services, while the broader virtual […]
Latest Articles
Country Specific Trends
What Are the Top CRDMO Companies in the U.S.?
The U.S. contract research, development, and manufacturing organization (CRDMO) industry has become one of the most important pillars of the
Insight Companies
Which Companies Are Associated With Owning Some of the Best-Known Consumer Health Brands?
The global consumer health industry has become one of the most powerful sectors within healthcare, supported by increasing awareness about
Insight Segments
HR+/HER2- Breast Cancer CDK4/6 Inhibitor Market Share: Palbociclib in the United States (2020–2024)
The U.S. HR-positive, HER2-negative breast cancer treatment market has witnessed major competitive shifts between 2020 and 2024, especially in the
Regional Trends
APAC Hospitals Expected to Increase Medical Device Spending Despite Slower Outlook in Japan
The medical device outlook across the Asia-Pacific remains highly positive as hospitals continue increasing investments in diagnostic systems, imaging equipment,
Latest Articles
OECD countries with top 10 mammography machines per 1,000,000
Breast cancer continues to be one of the most diagnosed cancers among women worldwide, and early screening remains one of
Latest Articles
Novartis’ Kisqali Hits USD 1.5 Billion Quarterly Sales as Pluvicto and Scemblix Drive Oncology Growth
Novartis is entering a new phase of growth powered by blockbuster cancer medicines, radioligand therapy innovation, and precision oncology expansion.
Insight Companies
How IQVIA Built a $16.3 Billion Healthcare Data Empire While Samsung Biologics Expanded to 784,000L Manufacturing Capacity
The global pharmaceutical CXO industry is no longer driven only by large drug companies. Behind many blockbuster medicines, vaccines, biologics,
Insight Companies
$8.44 Billion Cell and Gene Therapy for Oncology Market Sparks Global Investment War
Gilead Sciences Is Expanding Aggressively Beyond Traditional Oncology Gilead Sciences remains one of the strongest revenue generators in oncology cell
Latest Articles
Biotechnology Market 2024–2026: $200B+ Global Revenue Landscape, 50+ Drug Approvals & Billion-Dollar Blockbusters Driving Growth
The biotechnology industry has moved far beyond traditional pharma. Today, it is a high-tech ecosystem powered by gene editing, mRNA